Neudle.com: L dopa

Differential
(Click to cross reference)

abdominal protrusion

acetylcholine

acromegaly

adolescent medicine

advances in neurology

adverse drug reaction

affective disorders

agitation

akathisia

akinesia of eyelid function

alcohol, neurologic complications with

alcoholism

algorithm

alien hand syndrome

alpha methyldopa hydrazine

amphetamines, dyskinesia associated with

amygdala

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

anasarca

anemia, iron deficiency

anesthesia, general

ankle edema

anticholinergic drugs

anticholinergic drugs, side effects of

aphasia, progressive, primary

apraxia of eyelid opening

apraxia, constructional

aprazolam

aqueduct of Sylvius, stenosis

arm swing, reduced

arrhythmia, cardiac

artane

arterial dissection, aorta, cerebral symptoms with

aspartate aminotransferase

aspiration

asterixis

ataxia

attention deficit disorder with hyperactivity

atypical

audiogram

auditory and vestibular pathways

autonomic cardiovascular reflexes

autonomic dysfunction

autonomic dysfunction, evaluation of

autonomic nervous system

axillary nerve

Babinski sign

ballismus, bilateral

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benserazide

benzodiazepine

beta adrenergic blocker

brain implant, polymeric

brain transplantation

burst suppression pattern, electroencephalogram

CAT scan, emission, abnormal

catecholamine

catechol-o-methyltransferase inhibitor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction, subcortical

cerebral ischemia

cerebral palsy

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

cerebrovascular disease

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

controversies in neurology

Coombs test, positive

coprolalia

cortical-basal ganglionic degeneration

cyst, arachnoid, infant

dantrolene sodium

deanol

degenerative diseases of CNS

dementia, subcortical

dementia, treatment of

deprenyl

depression

desipramine

developmental milestones, loss of

differential diagnosis

dilantin

diplopia

disability rating scale, neurological

disability, neurological

diurnal variation

dizziness

dopa responsive dystonia

dopamine receptor, D2

dopaminergic dysfunction

drug induced neurologic disorders

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, children

dystonia, etiology of

dystonia, evaluation of

dystonia, face

dystonia, focal

dystonia, painful

dystonia, prevalence of

dystonia, symptomatic

dystonia, treatment of

echolalia

efficacy

electroconvulsive therapy

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electroencephalogram, triphasic delta waves

encephalopathy, progressive

epidemiology of neurology

equinovarus

ergotamine

evidence-based research

excitotoxin

exercise

extrapyramidal movement disorder, progressive

eye movement, disorders of

failed medical management

fine motor function, impaired

frontal behavioral spatial syndrome

gamma amino butyric acid

gastrointestinal bleeding

gastrostomy

gaze palsy

gaze palsy, supranuclear

genetic neurologic disorders

genetic screening

genetic testing

Gilles de la Tourette syndrome

glabellar sign

globus pallidus, stimulation

glomus jugulare tumor

groaning

guanidine

hallucination

hallucination, visual

head injury, brain stem lesion after

head injury, prognosis in

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

Huntington's chorea, presymptomatic detection of

hydrocephalus

hydroxyindole acetic acid 5(5HIAA)

hydroxytryptophan L-5(L-5 HTP)

hypotension, systemic

iatrogenic neurologic disorders

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, intranuclear

intranasal medication

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, intravenous

L-dopa, liquid

L-dopa, plasma concentration

L-dopa, potentiators of

Lewy body disease, diffuse

liver function enzymes

lobar atrophy

locus ceruleus, lesion of

lorazepam

madopar

manganese intoxication

memory, defect of recent

memory, impairment of

meningitis

mental status, abnormal

methysergide

metoclopramide

microangiopathy, brain

migraine, treatment of

mimics

Mini Mental Status Examination

misdiagnosis

mitochondrial disease

molecular genetics

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

multiple sclerosis, diet in

multiple sclerosis, treatment of

multiple system atrophy

muscle atrophy, static

myasthenic syndrome, treatment of

neoplasm, hormone producing

neoplasm, hormone producing, ectopic

neurochemistry

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic sensitivity

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease, diagnoses of

neurologic disease, tempo

neuronal degeneration

neuronal intranuclear inclusion disease

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, peripheral

neuroprotective agents

nigrostriatal pathway

norepinephrine

nortriptyline

obsessive-compulsive disorder

occupational neurologic disorders

ocular myopathy

ocular myopathy, differential diagnosis

olanzapine

old age, neurology of

ondansetron

ophthalmoplegia

oral contraceptives

oral contraceptives, choreiform movements with

orthostatic hypotension

orthostatic hypotension, idiopathic

orthostatic hypotension, treatment of

parasympathetic nervous system

paresthesias

Parkinson disease

Parkinson disease, akinetic form

Parkinson disease, arteriosclerotic

Parkinson disease, asymmetric onset

Parkinson disease, axial symptoms

Parkinson disease, benign tremulous

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, diet restricted in protein

Parkinson disease, differential diagnosis of

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, heterogeneity of

Parkinson disease, intractable

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, rapid onset

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

parsidol

pathologic gambling

patient information and support

penguin silhouette sign

pergolide

periodic limb movements

periodic movements during sleep

persistent vegetative state

personality change

phenothiazine

phenothiazine, dyskinesia associated with

pregnancy, neurologic complications in

pretectal syndrome

prevention of neurologic disorders

PRKN gene

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

pure autonomic failure

putamen, lesion of

pyramidal tract dysfunction

pyridoxine

pyridoxine deficiency

pyruvate-kinase deficiency anemia

quetiapine

raphe nuclei

rapid onset dystonia parkinsonism

rasagiline

rash

Red flags

reserpine and reserpine like drugs

reserpine treatment in movement disorder

respirations in CNS disease

respiratory dyskinesias

restless arms syndrome

restless leg syndrome

retrocollis

retropulsion

reversible neurologic disorder

risk-benefit assessment

ritalin

Romberg's sign

ropinirole

ropinirole, prolonged release

saccadic eye movements, abnormal

safety

scoliosis

seizure

seizure, pyridoxine dependent

selective serotonin reuptake inhibitors

self-mutilation

sequencing difficulty

serotonin

serotonin antagonist

serum alanine aminotransferase

short stature

shunt procedure, ventricular-complications of

Shy-Drager syndrome

sinemet

singing

single photon emission computed tomography

skin, biopsy

sleep

sleep pathology and physiology

small vessel disease

smell

Smell Identification Test

solvent

speech disorder

speech disorder, childhood

speech, soft

spinocerebellar ataxia

spinocerebellar ataxia type 1

spinocerebellar ataxia type 2

spinocerebellar ataxia type 3/Machado Joseph disease

stem cell transplantation

stereotaxic surgery

stereotyped behavior

stereotyped behavior, drug induced

stereotypy

steroid therapy, CNS treatment and complications with

stimulation, deep brain

subthalamic nucleus deep brain stimulation

swallow evaluation

sweating

sweating, abnormality of

sympathetic nervous system

sympathomimetic drugs

syncope

synucleinopathy

syphilis, neurologic complications with

systemic illness

tandem gait, ataxic

tardive dyskinesia

tardive dyskinesia, treatment of

thalamus, focused ultrasound ablation

toxins, nervous system

trauma

trazodone

treatment of neurologic disorder

tremor, surgical treatment of

tremor, thalamic stimulation for suppression of

tremor, treatment of

tricyclic antidepressant

trigeminal neuralgia

trinucleotide repeats

tripping

twins

tyrosine hydroxylase deficiency

varicella zoster virus

varicella zoster virus, encephalitis

vertigo, treatment of

vision, blurred

visual impairment

visual symptoms

visuospatial disturbance

walking, difficulty with

white matter disease, subcortical

wide based gait

Showing articles 300 to 350 of 352 << Previous Next >>

A New Metabolite Contributing to N-Acetyl Signal in 1H MRS of the Brain in Salla Disease
Neurol 52:1668-1672, Varho,T.,et al, 1999

Axonal Transection in the Lesions of Multiple Sclerosis
NEJM 338:278-285, 3231998., Trapp,B.D.,et al, 1998

Estimation of Brainstem Neuronal Loss in ALS with in Vivo Proton Magnetic Resonance Spectroscopy
Neurol 50:72-77, Cwik,V.A.,et al, 1998

White Matter Disease Induced by High-Dose Chemotherapy:MR Imaging & Proton Spectroscopy
AJNR 19:217-221, Brown,M.S.,et al, 1998

Functional & Metabolic Analysis of Cerebral Ischemia Using Magnetoencephalography & Proton MR Spectroscopy
Ann Neurol 42:554-563, 5391997., Kamada,K.,et al, 1997

Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996

The Eosinophilia-Myalgia Syndrome:Status of 205 Patients and Results of Treatment 2 Years After Onset
Ann Int Med 122:851-855, Hertzman,P.A.,et al, 1995

Levorotatory Form of 5-Hydroxytryptophan in Friedreich's Ataxia
Arch Neurol 52:456-460, Trouillas,P.,et al, 1995

Double-Blind Study with Levorotatory form of Hydroxytryptophan in Pts with Degen Cerebellar Dis
Arch Neurol 52:451-455, 4401995., Wessel,K.,et al, 1995

Detection of Cortical Neuron Loss in Motor Neuron Disease by Proton Magnetic Resonance Spectroscopic Imaging in Vivo
Neurol 44:1933-1938, Pioro,E.P.,et al, 1994

Magnetic Resonance Spectroscopy of N-Acetylaspartate in Hypoxic-Ischemic Encephalopathy
Ann Neurol 35:490-494, Graham,S.H.,et al, 1994

Comparison of Striatal 18F-dopa Uptake in Adult-Onset Dystonia-Parkinsonism, Parkinson's & Dopa-Responsive Dystonia
Neurol 43:1563-1568, Turjanski,N.,et al, 1993

Neurocognitive Dysfunction in the Eosinophilia-Myalgia Syndrome
Neurol 43:931-936, Krupp,L.B.,et al, 1993

Gerstmann's Syndrome
Arch Neurol 49:445-447, Benton,A.L., 1992

Eosinophilia-Myalgia Syndrome, Natural History in a Population-Based Cohort
Arch Int Med 152:1889-1892, Hedberg,K.,et al, 1992

Chronic Demyelinating Polyneuropathy Associated with Eosinophilia-Myalgia Syndrome
JNNP 55:352-358, Freimer,M.L.,et al, 1992

The Cause and pathogenesis of the Eosinophilia-Myalgia Syndrome
Ann Int Med 116:140-147, Varga,J.,et al, 1992

Eosinophilia-Myalgia Syndrome in L-Tryptophan-Exposed Patients
JAMA 267:77-82, Kamb,M.L.,et al, 1992

Acute Encephalopathy Associated with the Eosinophilia-Myalgia Syndrome
Neurol 42:461-462, Adair,J.C.,et al, 1992

Eosinophilia-Myalgia Syndrome Associated with Ingestion of L-Tryptophan:Muscle Biopsy Findings in 4 Patients
Neurol 41:319-321, Hollander,D.&Adelman,L.S., 1991

Eosinophilia-Myalgia Syndrome, A Clinical Case Series of 21 Patients
Arch Int Med 151:533-537, Philen,R.M.,et al, 1991

Long-term Acetyl-L-Carnitine Treatment in Alzheimer's Disease
Neurol 41:1726-1732, Spagnoli,A.,et al, 1991

Neurologic Compliations of the Tryptophan-Associated Eosinophilia-Myalgia Syndrome
Arch Neurol 48:436-438, Tolander,L.M.,et al, 1991

Dopa-responsive Dystonia:[18F]Dopa Positron Emission Tomography
Ann Neurol 30:24-30, Sawle,G.V.,et al, 1991

Peripheral Neuropathy Associated with Eosinophilia-Myalgia Syndrome
Ann Neurol 28:522-528, Heiman-Patterson,T.D.,et al, 1990

Mononeuropathy Multiplex in Tryptophan-Associated Eosinophilia-Myalgia Syndrome
Neurol 40:1632-1633, Selwa,J.F.,et al, 1990

Right-Left Disorientation in Dementia of the Alzheimer Type
Neurol 40:1619-1620, Fischer,P.,et al, 1990

Two Patients with Eosinophilia Myalgia Syndrome Associated with Tryptophan
BMJ 301:21, VanGarsse,L.G.M.&Boeykens,P.P.H., 1990

Peripheral Neuropathy in the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion
Neurol 40 1035-1040, Smith,B.E.&Dyck,P.J., 1990

The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion
Ann Int Med 113:124-134, Martin,R.W.,et al, 1990

L-Tryptophan-Associated Eosinophilic Perimyositis, Neuritis, and Fasciitis
Medicine 69:187-199, Kaufman,L.D.,et al, 1990

L-Tryptophan-Induced Eosinophila-Myalgia Syndrome and Myopathy
Neurol 40:1629-1630, Sagman,D.L.&Melamed,J.C., 1990

L-tryptophan and Eosinophilia-Myalgia Syndrome in New Mexico
Lancet 335:645-648, Eidson,M.,et al, 1990

Interim Guidance on the Eosinophilia-Myalgia Syndrome
Ann Int Med 112:85-87, Kilbourne,E.M.,et al, 1990

A Case of the Eosinophilia-Myalgia Syndrome Associated with Use of an L-Tryptophan
Ann Int Med 112:300-301, Flannery,M.T.,et al, 1990

Clinicopath Conf
Eosinophilic Fasciitis, Case Study 4-1990, NEJM 322:252-261, 93190., , 1990

Development of Diffuse Fasciitis with Eosinophilia During L-Tryptophan Treatment:Elevated Type I Collagen Gene
Ann Int Med 112:344-351, Varga,J.,et al, 1990

Scleroderma, fasciitis, and Eosinophilia Associated with the Ingestion of Tryptophan
NEJM 322:874-881, 9261990., Silver,R.M.,et al, 1990

Association of the Eosinophilia-Myalgia Syndrome with the Ingestion of Tryptophan
NEJM 322:869-873, 9261990., Hertzman,P.A.,et al, 1990

Tryptophan-Induced Eosinophilia-Myalgia Syndrome
NEJM 322:926-928, Medsger,T.A., 1990

Eosinophilia-Myalgia Syndrome-New Mexico
JAMA 262:3116, Belvins,W.L.,et al, 1989

Cerebrovascular Complications of L-Asparaginase Therapy
Neurol 38:127-133, Feinberg,W.M.&Swenson,M.R., 1988

Progressive Myoclonus Epilepsies:Specific Causes & Diagnosis
NEJM 315:296-305, Berkovic,S.F.,et al, 1986

Stroke Due to Treatment with L-Asparginase in an Adult
NEJM 307:1643, Lederman,G.S., 1982

Neurotoxicity of the Pyrimidine Synthesis Inhibitor N-Phosphonoacetyl-L-Aspartate
Ann Neurol 12:175-183, Wiley,R.G.,et al, 1982

Dural Sinus Thrombosis in Children With Acute Lympho-blastic Leukemia
JAMA 246:2837-2839, Steinherz,P.G.,et al, 1981

Peripheral Neuropathy in the Cherry-Red Spot-Myoclonus Syndrome (Sialidosis Type I)
Ann Neurol 7:450-456, Steinman,L.,et al, 1980

Mirror-reading & Writing in Association with Right-left Spatial Disorientation
JNNP 43:774-780, Heilman,K.M.,et al, 1980

Exacerbation of Parkinsonism by Methyldopa
JAMA 244:2727-2728, Rosenblum,A.M.&Montgomery,E.B., 1980

Neurologic Soft Signs in Schizophrenia & Character Disorders
Arch Gen Psych 33:845-853, Quitkin,R.,et al, 1976

Showing articles 300 to 350 of 352 << Previous Next >>